Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Drugmaker Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts

Pfizer reported better-than-expected second-quarter results on Tuesday, powered by strong demand for blood thinner Eliquis and recently acquired drugs, and announced plans for an additional $2.5 billion in savings from cost cutting.

The New York-based drugmaker now expects $9.7 billion in total net savings from its cost slashing through 2029 as it seeks to offset declining COVID-related revenue and ‌restore sustainable growth.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.